Status | Study |
Completed |
Study Name: Retrospective Evaluation of Liposarcoma Condition: Survival , Tumor Date: 2017-01-22 Interventions: Procedure: Patients with Liposarcoma Evaluation of Liposarcoma treated in a single center |
Recruiting |
Study Name: A Pilot Study of NY-ESO-1ᶜ²⁵⁹T Cells in Subjects With Advanced Myxoid/ Round Cell Liposarcoma Condition: Myxoid Round Cell Liposarcoma High Grade Myxoid Liposarcoma Date: 2016-12-12 Interventions: Genetic: Autologous genetically modified T Cells, NY-ESO-1ᶜ²⁵⁹T Cytoreductive che |
Recruiting |
Study Name: A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma Condition: Liposarcomas, Dedifferentiated Liposarcoma - Well Differentiated Date: 2016-11-29 Interventions: Drug: Ribociclib Ribociclib Oral 600 mg x 1 a day 21 days on 1 week off in 28 days cycles |
Recruiting |
Study Name: MGCD516 in Advanced Liposarcoma and Other Soft Tissue Sarcomas Condition: Liposarcoma Metastatic Liposarcoma Date: 2016-11-29 Interventions: Drug: MGCD516 Administered at 150 mg orally, daily, in continuous 21 day cycles. An orally available, po |
Recruiting |
Study Name: Study of Abemaciclib in Dedifferentiated Liposarcoma Condition: Sarcoma Dedifferentiated Liposarcoma Date: 2016-07-25 Interventions: Drug: Abemaciclib Other Name: LY2835219 |
Not yet recruiting |
Study Name: Ultra-sounded Guided Regional Blockade for Lipoma Excision Condition: Lipomas Date: 2016-04-24 Interventions: Procedure: Ultrasound guidance In the second arm, ultrasound will be used to guide the regional block |
Recruiting |
Study Name: Developing a Biomarker for Monitoring Clinical Outcomes in Children With Spinal Lipoma. Condition: Lipoma of Spinal Cord Date: 2016-03-16 Interventions: Procedure: Blood and urine sampling |
Recruiting |
Study Name: Selinexor in Advanced Liposarcoma Condition: Dedifferentiated Liposarcoma Date: 2015-10-13 Interventions: Drug: Selinexor Selinexor 60mg |
Active, not recruiting |
Study Name: A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma Condition: Liposarcoma Soft Tissue Sarcoma Date: 2015-10-06 Interventions: Drug: ribociclib Oral, 600 mg x 1 a day, duration - according to response |
Recruiting |
Study Name: Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus Condition: Sporadic Angiomyolipomas (AMLs) Date: 2015-08-20 Interventions: Drug: Everolimus 10 mg tablets |